Literature DB >> 14688160

Comparison between the sublingual and oral route of misoprostol for pre-abortion cervical priming in first trimester abortions.

Pikee Saxena1, Sudha Salhan, Nivedita Sarda.   

Abstract

BACKGROUND: Misoprostol has been used for achieving cervical priming before suction evacuation (SE) by the oral or vaginal route, although both routes have their shortcomings. We evaluated the efficacy of the sublingual versus oral route of misoprostol for cervical priming before SE.
METHODS: A prospective clinical trial was carried out in 100 women with a period of gestation of between 6 and 12 weeks who were sequentially allocated to two groups of 50 each. Both groups received 400 microg of misoprostol 3 h prior to SE by either the sublingual or the oral route.
RESULTS: Demographically, both groups were similar. For all periods of gestation, sublingual misoprostol significantly improved cervical dilation (P<0.001) with a reduction in duration of surgery (P=0.024) compared with the oral route. Mean (+/- SD) pain scores for the sublingual and oral groups were similar (2.6 +/- 1.4 versus 3.5 +/- 1.1). No major complications occurred in either of the two groups.
CONCLUSION: the sublingual route is an effective alternative to oral administration of misoprostol for cervical dilation. To the best of our knowledge, this is the first study to compare the efficacy of the sublingual versus the oral route of misoprostol for cervical priming before SE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688160     DOI: 10.1093/humrep/deh001

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  3 in total

1.  Comparison of sublingual, vaginal, and oral misoprostol in cervical ripening for first trimester abortion.

Authors:  Shagufta Parveen; Zaffar Abbas Khateeb; S M Mufti; M A Shah; Vishal R Tandon; S Hakak; Z Singh; Shagufta Yasmeen; Shakeel A Mir; Rehana Tabasum; Nasreen Jan
Journal:  Indian J Pharmacol       Date:  2011-04       Impact factor: 1.200

2.  Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise.

Authors:  Devendra Singh Kushwah; Beenu Kushwah; Mohd Tariq Salman; V K Verma
Journal:  Indian J Pharmacol       Date:  2011-05       Impact factor: 1.200

3.  Comparison of sublingual and vaginal misoprostol for second-trimester pregnancy terminations.

Authors:  Forozan Milani; Seyede Hajar Sharami; Saeedeh Arjmandi
Journal:  J Family Reprod Health       Date:  2014-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.